Overview
Background
Customer, is a US headquartered leading third-party vendor specializing in Clinical Trial Disclosure and transparency services. Customer offers innovative technologies and expert services to meet global clinical trial transparency requirements
To accelerate its digital journey, our customer decided to establish a development center in India.
Business Challenge
Customer had successful running teams of analysts and domain experts in Tier 1 city in India, and wanted to expand its operations into IT and software development functions. However, lack of India presence was imposing challenges to the customer.
- Attrition and instability due to high attrition and instability in the IT industry in India
- Lack of experience and India presence in IT industry was posing challenges to attract, retain and manage its development function in India.
Solution
The proposed offshore delivery center solution allowed the customer to focus on its core business while Tech Radix would help to set up, stabilize, transform, and eventually transition back the delivery canter. Our proven BOT (Build, Operate & Transfer) model, a hybrid option, offers customer to acquire essential Software Delivery capabilities from India and the advantages of outsourcing without sacrificing control, time, and resources to build on its own.
Tech Radix successfully worked with the customer to design, incubate, and operate the India software delivery team, compressing the time-to-value period and rapidly scaling capabilities while minimizing Customers capital investment.
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit,
Industry Leader
Entreprenuer, Expert Service Pvt. Ltd.
Approach
- A US based pharma company :- wanting to setup their Software Development R&D center in India. We helped setup a 20+ member R&D team in the BOT – Build Operate Transfer model.
- Lorem ipsum dolor sit amet, consectetur:- adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
- Duis aute irure dolor in reprehenderit:- in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Results
42%
Under Cost Per Action Goal
21%
Conversion Ratio in 2020
162
Conversion tracked across all transactions
Conclusion
A US based pharma company :- wanting to setup their Software Development R&D center in India. We helped setup a 20+ member R&D team in the BOT – Build Operate Transfer model.
Lorem ipsum dolor sit amet, consectetur:- adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Duis aute irure dolor in reprehenderit:- in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.